

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 6.76680966 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.76680966 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 6.36078972 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.36078972 |
| 5 | alpha-linolenic acid metabolic process (GO:0036109) | 5.74661043 |
| 6 | aromatic amino acid family catabolic process (GO:0009074) | 5.61273960 |
| 7 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.07089647 |
| 8 | bile acid biosynthetic process (GO:0006699) | 5.06971524 |
| 9 | cysteine metabolic process (GO:0006534) | 4.93732739 |
| 10 | proteasome assembly (GO:0043248) | 4.83576229 |
| 11 | glyoxylate metabolic process (GO:0046487) | 4.79145077 |
| 12 | sulfur amino acid catabolic process (GO:0000098) | 4.74040724 |
| 13 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.65558362 |
| 14 | regulation of triglyceride catabolic process (GO:0010896) | 4.62651455 |
| 15 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.62229637 |
| 16 | tryptophan catabolic process (GO:0006569) | 4.61309690 |
| 17 | indole-containing compound catabolic process (GO:0042436) | 4.61309690 |
| 18 | indolalkylamine catabolic process (GO:0046218) | 4.61309690 |
| 19 | fatty acid homeostasis (GO:0055089) | 4.60560001 |
| 20 | acetyl-CoA metabolic process (GO:0006084) | 4.56697057 |
| 21 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 4.56593782 |
| 22 | complement activation, alternative pathway (GO:0006957) | 4.47123830 |
| 23 | kynurenine metabolic process (GO:0070189) | 4.45314646 |
| 24 | urea cycle (GO:0000050) | 4.41583771 |
| 25 | urea metabolic process (GO:0019627) | 4.41583771 |
| 26 | thioester biosynthetic process (GO:0035384) | 4.39885346 |
| 27 | acyl-CoA biosynthetic process (GO:0071616) | 4.39885346 |
| 28 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 4.38797257 |
| 29 | tryptophan metabolic process (GO:0006568) | 4.37295268 |
| 30 | bile acid metabolic process (GO:0008206) | 4.29651214 |
| 31 | short-chain fatty acid metabolic process (GO:0046459) | 4.25064487 |
| 32 | tyrosine metabolic process (GO:0006570) | 4.24718149 |
| 33 | ethanol oxidation (GO:0006069) | 4.24130861 |
| 34 | fatty acid beta-oxidation (GO:0006635) | 4.21553494 |
| 35 | valine metabolic process (GO:0006573) | 4.21534545 |
| 36 | fatty acid elongation (GO:0030497) | 4.21152229 |
| 37 | protein neddylation (GO:0045116) | 4.19366956 |
| 38 | cellular ketone body metabolic process (GO:0046950) | 4.17051881 |
| 39 | fatty-acyl-CoA metabolic process (GO:0035337) | 4.16270721 |
| 40 | plasma lipoprotein particle clearance (GO:0034381) | 4.14224179 |
| 41 | lysine catabolic process (GO:0006554) | 4.12553367 |
| 42 | lysine metabolic process (GO:0006553) | 4.12553367 |
| 43 | nitrogen cycle metabolic process (GO:0071941) | 4.11776167 |
| 44 | triglyceride homeostasis (GO:0070328) | 4.11408737 |
| 45 | acylglycerol homeostasis (GO:0055090) | 4.11408737 |
| 46 | high-density lipoprotein particle remodeling (GO:0034375) | 4.10850510 |
| 47 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.10549030 |
| 48 | ATP synthesis coupled proton transport (GO:0015986) | 4.10549030 |
| 49 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.09898466 |
| 50 | protein carboxylation (GO:0018214) | 4.09898466 |
| 51 | coenzyme catabolic process (GO:0009109) | 4.09854739 |
| 52 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 4.09431841 |
| 53 | aromatic amino acid family metabolic process (GO:0009072) | 4.06787694 |
| 54 | biotin metabolic process (GO:0006768) | 4.05624460 |
| 55 | fatty acid catabolic process (GO:0009062) | 4.04918939 |
| 56 | fatty acid oxidation (GO:0019395) | 4.02561409 |
| 57 | negative regulation of fibrinolysis (GO:0051918) | 4.02550255 |
| 58 | regulation of protein activation cascade (GO:2000257) | 4.00801188 |
| 59 | very long-chain fatty acid metabolic process (GO:0000038) | 3.98224510 |
| 60 | branched-chain amino acid catabolic process (GO:0009083) | 3.95797105 |
| 61 | lipid oxidation (GO:0034440) | 3.94649737 |
| 62 | alpha-amino acid catabolic process (GO:1901606) | 3.94244837 |
| 63 | amino-acid betaine metabolic process (GO:0006577) | 3.94152021 |
| 64 | regulation of fibrinolysis (GO:0051917) | 3.94055592 |
| 65 | regulation of sequestering of triglyceride (GO:0010889) | 3.93583904 |
| 66 | acyl-CoA metabolic process (GO:0006637) | 3.91703375 |
| 67 | thioester metabolic process (GO:0035383) | 3.91703375 |
| 68 | monocarboxylic acid catabolic process (GO:0072329) | 3.82869420 |
| 69 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 3.80979190 |
| 70 | triglyceride catabolic process (GO:0019433) | 3.80937154 |
| 71 | serine family amino acid catabolic process (GO:0009071) | 3.80146194 |
| 72 | regulation of complement activation (GO:0030449) | 3.77347663 |
| 73 | cellular amino acid catabolic process (GO:0009063) | 3.76750199 |
| 74 | DNA double-strand break processing (GO:0000729) | 3.75126552 |
| 75 | cullin deneddylation (GO:0010388) | 3.70291849 |
| 76 | homocysteine metabolic process (GO:0050667) | 3.69811608 |
| 77 | ketone body metabolic process (GO:1902224) | 3.69328926 |
| 78 | neutral lipid catabolic process (GO:0046461) | 3.69066516 |
| 79 | acylglycerol catabolic process (GO:0046464) | 3.69066516 |
| 80 | branched-chain amino acid metabolic process (GO:0009081) | 3.68122780 |
| 81 | protein-lipid complex remodeling (GO:0034368) | 3.66342345 |
| 82 | macromolecular complex remodeling (GO:0034367) | 3.66342345 |
| 83 | plasma lipoprotein particle remodeling (GO:0034369) | 3.66342345 |
| 84 | carboxylic acid catabolic process (GO:0046395) | 3.61921240 |
| 85 | organic acid catabolic process (GO:0016054) | 3.61921240 |
| 86 | regulation of cholesterol esterification (GO:0010872) | 3.61871039 |
| 87 | cellular glucuronidation (GO:0052695) | 3.61558588 |
| 88 | positive regulation of lipid catabolic process (GO:0050996) | 3.61153257 |
| 89 | oxidative phosphorylation (GO:0006119) | 3.57609417 |
| 90 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.57453661 |
| 91 | reverse cholesterol transport (GO:0043691) | 3.57218163 |
| 92 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.55897247 |
| 93 | negative regulation of lipase activity (GO:0060192) | 3.54488013 |
| 94 | chaperone-mediated protein transport (GO:0072321) | 3.52172685 |
| 95 | fatty acid transmembrane transport (GO:1902001) | 3.50260560 |
| 96 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.50123169 |
| 97 | respiratory electron transport chain (GO:0022904) | 3.49540016 |
| 98 | low-density lipoprotein particle clearance (GO:0034383) | 3.49473999 |
| 99 | regulation of cholesterol metabolic process (GO:0090181) | 3.48822730 |
| 100 | cofactor catabolic process (GO:0051187) | 3.48589717 |
| 101 | aspartate family amino acid catabolic process (GO:0009068) | 3.46608590 |
| 102 | glutamate metabolic process (GO:0006536) | 3.43465695 |
| 103 | serine family amino acid metabolic process (GO:0009069) | 3.41735685 |
| 104 | triglyceride metabolic process (GO:0006641) | 3.41593945 |
| 105 | electron transport chain (GO:0022900) | 3.38644456 |
| 106 | protein deneddylation (GO:0000338) | 3.38488757 |
| 107 | CENP-A containing nucleosome assembly (GO:0034080) | 3.37870231 |
| 108 | chromatin remodeling at centromere (GO:0031055) | 3.37769049 |
| 109 | triglyceride biosynthetic process (GO:0019432) | 3.36600813 |
| 110 | ethanol metabolic process (GO:0006067) | 3.34937216 |
| 111 | bile acid and bile salt transport (GO:0015721) | 3.34718147 |
| 112 | neutral lipid biosynthetic process (GO:0046460) | 3.33635621 |
| 113 | acylglycerol biosynthetic process (GO:0046463) | 3.33635621 |
| 114 | phospholipid efflux (GO:0033700) | 3.33253383 |
| 115 | aldehyde catabolic process (GO:0046185) | 3.32239628 |
| 116 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.31758177 |
| 117 | amine catabolic process (GO:0009310) | 3.31028694 |
| 118 | cellular biogenic amine catabolic process (GO:0042402) | 3.31028694 |
| 119 | serine family amino acid biosynthetic process (GO:0009070) | 3.30786670 |
| 120 | lipid particle organization (GO:0034389) | 3.29851942 |
| 121 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.24990684 |
| 122 | tricarboxylic acid cycle (GO:0006099) | 3.24654309 |
| 123 | ribosome assembly (GO:0042255) | 3.22122011 |
| 124 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.21225059 |
| 125 | brown fat cell differentiation (GO:0050873) | 3.21099787 |
| 126 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.19140497 |
| 127 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.18492917 |
| 128 | negative regulation of ligase activity (GO:0051352) | 3.18492917 |
| 129 | glycerol metabolic process (GO:0006071) | 3.16787767 |
| 130 | cholesterol biosynthetic process (GO:0006695) | 3.16260235 |
| 131 | establishment of integrated proviral latency (GO:0075713) | 3.15955000 |
| 132 | ether lipid metabolic process (GO:0046485) | 3.11874302 |
| 133 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.07855187 |
| 134 | response to nitrosative stress (GO:0051409) | 3.07187701 |
| 135 | sterol biosynthetic process (GO:0016126) | 3.06169639 |
| 136 | histone mRNA metabolic process (GO:0008334) | 3.03407371 |
| 137 | organelle disassembly (GO:1903008) | 3.03199717 |
| 138 | primary alcohol metabolic process (GO:0034308) | 3.03137036 |
| 139 | respiratory chain complex IV assembly (GO:0008535) | 3.03081217 |
| 140 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.00991073 |
| 141 | formation of translation preinitiation complex (GO:0001731) | 3.00292906 |
| 142 | DNA catabolic process, exonucleolytic (GO:0000738) | 2.98199762 |
| 143 | phospholipid homeostasis (GO:0055091) | 2.97571556 |
| 144 | purine nucleobase biosynthetic process (GO:0009113) | 2.97563287 |
| 145 | ribonucleoprotein complex disassembly (GO:0032988) | 2.96295540 |
| 146 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.96292557 |
| 147 | L-methionine salvage (GO:0071267) | 2.93724975 |
| 148 | L-methionine biosynthetic process (GO:0071265) | 2.93724975 |
| 149 | amino acid salvage (GO:0043102) | 2.93724975 |
| 150 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.92575868 |
| 151 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.92575868 |
| 152 | NADH dehydrogenase complex assembly (GO:0010257) | 2.92575868 |
| 153 | NADH metabolic process (GO:0006734) | 2.92458982 |
| 154 | response to phenylpropanoid (GO:0080184) | 2.91898617 |
| 155 | doxorubicin metabolic process (GO:0044598) | 2.90338315 |
| 156 | daunorubicin metabolic process (GO:0044597) | 2.90338315 |
| 157 | polyketide metabolic process (GO:0030638) | 2.90338315 |
| 158 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.89785349 |
| 159 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.88779683 |
| 160 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.88779683 |
| 161 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.88779683 |
| 162 | glycerol ether metabolic process (GO:0006662) | 2.86728020 |
| 163 | termination of RNA polymerase III transcription (GO:0006386) | 2.86530474 |
| 164 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.86530474 |
| 165 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.83633909 |
| 166 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.83633909 |
| 167 | protein complex biogenesis (GO:0070271) | 2.82749006 |
| 168 | alditol metabolic process (GO:0019400) | 2.80596759 |
| 169 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.80464654 |
| 170 | DNA damage response, detection of DNA damage (GO:0042769) | 2.77703656 |
| 171 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.76957887 |
| 172 | protein targeting to mitochondrion (GO:0006626) | 2.76804369 |
| 173 | rRNA modification (GO:0000154) | 2.76717497 |
| 174 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.73390506 |
| 175 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.73390506 |
| 176 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.72987244 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.72372872 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 7.65477815 |
| 3 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.86730933 |
| 4 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.74841210 |
| 5 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.57909889 |
| 6 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.52238237 |
| 7 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.70853344 |
| 8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.34479297 |
| 9 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.08981594 |
| 10 | * GABP_17652178_ChIP-ChIP_JURKAT_Human | 4.05933404 |
| 11 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.38390829 |
| 12 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.26831874 |
| 13 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.24563678 |
| 14 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.20175443 |
| 15 | ELK1_19687146_ChIP-ChIP_HELA_Human | 3.11590426 |
| 16 | * E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.69456252 |
| 17 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.69240140 |
| 18 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.54680803 |
| 19 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.45823908 |
| 20 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.44495683 |
| 21 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.40887460 |
| 22 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.37667310 |
| 23 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.34170839 |
| 24 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.34014114 |
| 25 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.27280141 |
| 26 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.26914487 |
| 27 | * PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.12137551 |
| 28 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.11921990 |
| 29 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.08290521 |
| 30 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 2.05051267 |
| 31 | FUS_26573619_Chip-Seq_HEK293_Human | 1.99741314 |
| 32 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.94100508 |
| 33 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.90925771 |
| 34 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.89274506 |
| 35 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.83600908 |
| 36 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.83406415 |
| 37 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.82949046 |
| 38 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.79350367 |
| 39 | * EWS_26573619_Chip-Seq_HEK293_Human | 1.78676714 |
| 40 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 1.78047995 |
| 41 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.77034020 |
| 42 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.73490293 |
| 43 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.72840575 |
| 44 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.68650676 |
| 45 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.67008842 |
| 46 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.64526603 |
| 47 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.62306595 |
| 48 | VDR_22108803_ChIP-Seq_LS180_Human | 1.61735746 |
| 49 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.60992844 |
| 50 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.57259239 |
| 51 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.56998828 |
| 52 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.53300213 |
| 53 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.53041872 |
| 54 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.51856160 |
| 55 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.47676419 |
| 56 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.46814656 |
| 57 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.46315654 |
| 58 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.42601599 |
| 59 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.38601504 |
| 60 | GATA1_22025678_ChIP-Seq_K562_Human | 1.37455281 |
| 61 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.36726425 |
| 62 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.36250340 |
| 63 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.36118562 |
| 64 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.35649621 |
| 65 | * ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.29363652 |
| 66 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.27820184 |
| 67 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.27615869 |
| 68 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.27615869 |
| 69 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.26665985 |
| 70 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.21751134 |
| 71 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.20729518 |
| 72 | * MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.19071264 |
| 73 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.18984827 |
| 74 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.17918387 |
| 75 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.13791562 |
| 76 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.13470620 |
| 77 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.13338323 |
| 78 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.11959854 |
| 79 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.11189864 |
| 80 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.10241055 |
| 81 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.09465949 |
| 82 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.08420104 |
| 83 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.06813451 |
| 84 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.04438043 |
| 85 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.03989223 |
| 86 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.03538577 |
| 87 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.03279970 |
| 88 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.02695262 |
| 89 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.01979088 |
| 90 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.01442186 |
| 91 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.01407911 |
| 92 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.01009941 |
| 93 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.00476694 |
| 94 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.98713660 |
| 95 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.98296538 |
| 96 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.98208759 |
| 97 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.97689567 |
| 98 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.97488378 |
| 99 | * SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.96869864 |
| 100 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.96612769 |
| 101 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.96295594 |
| 102 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.95785452 |
| 103 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.95607223 |
| 104 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.95044250 |
| 105 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.93816449 |
| 106 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.93688093 |
| 107 | * FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.92581765 |
| 108 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.92527145 |
| 109 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.91456784 |
| 110 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.91212031 |
| 111 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.90064028 |
| 112 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 0.89458607 |
| 113 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.88724530 |
| 114 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.88680037 |
| 115 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.87086075 |
| 116 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 0.86843304 |
| 117 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.86125431 |
| 118 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.83194219 |
| 119 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.82958033 |
| 120 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.79800853 |
| 121 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.78661265 |
| 122 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.77665290 |
| 123 | CBP_21632823_ChIP-Seq_H3396_Human | 0.76327773 |
| 124 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.75362658 |
| 125 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.74996650 |
| 126 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.74017875 |
| 127 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.73265351 |
| 128 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.70930218 |
| 129 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.70920151 |
| 130 | * FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.70279041 |
| 131 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.70179047 |
| 132 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.69846800 |
| 133 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.69658168 |
| 134 | AR_20517297_ChIP-Seq_VCAP_Human | 0.68270023 |
| 135 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.68202617 |
| 136 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.66970776 |
| 137 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.66689788 |
| 138 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.66563681 |
| 139 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.66489306 |
| 140 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.66085069 |
| 141 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.63713451 |
| 142 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.63082697 |
| 143 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.62193648 |
| 144 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.62193648 |
| 145 | * NANOG_19829295_ChIP-Seq_ESCs_Human | 0.60477155 |
| 146 | * SOX2_19829295_ChIP-Seq_ESCs_Human | 0.60477155 |
| 147 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.59256993 |
| 148 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.58825779 |
| 149 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.58427187 |
| 150 | NCOR_22424771_ChIP-Seq_293T_Human | 0.56689863 |
| 151 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.56319782 |
| 152 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.55942420 |
| 153 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.55752448 |
| 154 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.55428190 |
| 155 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.53596008 |
| 156 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.52248636 |
| 157 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.51555601 |
| 158 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.50818432 |
| 159 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.50258996 |
| 160 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.50107695 |
| 161 | * CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.50005448 |
| 162 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.49895016 |
| 163 | * PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.49861473 |
| 164 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.49387504 |
| 165 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.49281765 |
| 166 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.49150447 |
| 167 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.49133603 |
| 168 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.49100444 |
| 169 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.48767821 |
| 170 | P300_19829295_ChIP-Seq_ESCs_Human | 0.48477682 |
| 171 | * SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.48438803 |
| 172 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.48075074 |
| 173 | * FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.47121075 |
| 174 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.47039744 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.41724951 |
| 2 | MP0005360_urolithiasis | 6.48632961 |
| 3 | MP0005365_abnormal_bile_salt | 5.37852713 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 5.31818317 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.27649357 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.14974107 |
| 7 | MP0010329_abnormal_lipoprotein_level | 3.55376971 |
| 8 | MP0003252_abnormal_bile_duct | 2.99846544 |
| 9 | MP0008058_abnormal_DNA_repair | 2.90289006 |
| 10 | MP0003195_calcinosis | 2.67741320 |
| 11 | MP0005332_abnormal_amino_acid | 2.67556093 |
| 12 | MP0005083_abnormal_biliary_tract | 2.62129952 |
| 13 | MP0002118_abnormal_lipid_homeostasis | 2.47379717 |
| 14 | MP0005670_abnormal_white_adipose | 2.43992672 |
| 15 | MP0009840_abnormal_foam_cell | 2.42343818 |
| 16 | MP0001666_abnormal_nutrient_absorption | 2.33230419 |
| 17 | MP0010094_abnormal_chromosome_stability | 2.21042422 |
| 18 | MP0003191_abnormal_cellular_cholesterol | 2.12639256 |
| 19 | MP0004957_abnormal_blastocyst_morpholog | 2.11100827 |
| 20 | MP0002102_abnormal_ear_morphology | 2.10417888 |
| 21 | MP0004130_abnormal_muscle_cell | 2.04548784 |
| 22 | MP0000372_irregular_coat_pigmentation | 2.03978881 |
| 23 | MP0000609_abnormal_liver_physiology | 2.02672492 |
| 24 | MP0008057_abnormal_DNA_replication | 1.98961033 |
| 25 | MP0005666_abnormal_adipose_tissue | 1.86089428 |
| 26 | MP0001529_abnormal_vocalization | 1.82314013 |
| 27 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.81741427 |
| 28 | MP0004019_abnormal_vitamin_homeostasis | 1.73466302 |
| 29 | MP0008007_abnormal_cellular_replicative | 1.73168083 |
| 30 | MP0003186_abnormal_redox_activity | 1.68318554 |
| 31 | MP0004185_abnormal_adipocyte_glucose | 1.67090202 |
| 32 | MP0001764_abnormal_homeostasis | 1.66346124 |
| 33 | MP0005319_abnormal_enzyme/_coenzyme | 1.61441662 |
| 34 | MP0002971_abnormal_brown_adipose | 1.60428123 |
| 35 | MP0002876_abnormal_thyroid_physiology | 1.56996358 |
| 36 | MP0003011_delayed_dark_adaptation | 1.56323795 |
| 37 | MP0003868_abnormal_feces_composition | 1.53723187 |
| 38 | MP0009697_abnormal_copulation | 1.49726653 |
| 39 | MP0003693_abnormal_embryo_hatching | 1.47347747 |
| 40 | MP0003567_abnormal_fetal_cardiomyocyte | 1.46614198 |
| 41 | MP0006036_abnormal_mitochondrial_physio | 1.43283523 |
| 42 | MP0006054_spinal_hemorrhage | 1.39950050 |
| 43 | MP0003690_abnormal_glial_cell | 1.37699656 |
| 44 | MP0003656_abnormal_erythrocyte_physiolo | 1.35954928 |
| 45 | MP0009672_abnormal_birth_weight | 1.31159435 |
| 46 | MP0001661_extended_life_span | 1.30448843 |
| 47 | MP0004147_increased_porphyrin_level | 1.29508587 |
| 48 | MP0009643_abnormal_urine_homeostasis | 1.28357240 |
| 49 | MP0002138_abnormal_hepatobiliary_system | 1.27254594 |
| 50 | MP0005535_abnormal_body_temperature | 1.24544091 |
| 51 | MP0002254_reproductive_system_inflammat | 1.23228711 |
| 52 | MP0005375_adipose_tissue_phenotype | 1.22158097 |
| 53 | MP0005451_abnormal_body_composition | 1.20721720 |
| 54 | MP0002837_dystrophic_cardiac_calcinosis | 1.20683693 |
| 55 | MP0001188_hyperpigmentation | 1.19071777 |
| 56 | MP0004215_abnormal_myocardial_fiber | 1.17906258 |
| 57 | MP0003077_abnormal_cell_cycle | 1.17359350 |
| 58 | MP0005334_abnormal_fat_pad | 1.17045391 |
| 59 | MP0002938_white_spotting | 1.16462757 |
| 60 | MP0003718_maternal_effect | 1.16038835 |
| 61 | MP0000604_amyloidosis | 1.15979937 |
| 62 | MP0003941_abnormal_skin_development | 1.15598509 |
| 63 | MP0008932_abnormal_embryonic_tissue | 1.13323341 |
| 64 | MP0003111_abnormal_nucleus_morphology | 1.10767189 |
| 65 | MP0003329_amyloid_beta_deposits | 1.09976330 |
| 66 | MP0000343_altered_response_to | 1.09067298 |
| 67 | MP0002078_abnormal_glucose_homeostasis | 1.05213116 |
| 68 | MP0000920_abnormal_myelination | 1.04418657 |
| 69 | MP0005075_abnormal_melanosome_morpholog | 1.03822963 |
| 70 | MP0006072_abnormal_retinal_apoptosis | 1.02429422 |
| 71 | MP0000569_abnormal_digit_pigmentation | 1.01442700 |
| 72 | MP0002796_impaired_skin_barrier | 1.00874096 |
| 73 | MP0003136_yellow_coat_color | 1.00450365 |
| 74 | MP0008438_abnormal_cutaneous_collagen | 0.98584032 |
| 75 | MP0001881_abnormal_mammary_gland | 0.98355745 |
| 76 | MP0008789_abnormal_olfactory_epithelium | 0.95481592 |
| 77 | MP0003221_abnormal_cardiomyocyte_apopto | 0.95230266 |
| 78 | MP0005636_abnormal_mineral_homeostasis | 0.94770329 |
| 79 | MP0005647_abnormal_sex_gland | 0.94530721 |
| 80 | MP0003786_premature_aging | 0.91847187 |
| 81 | MP0000598_abnormal_liver_morphology | 0.91163167 |
| 82 | MP0004043_abnormal_pH_regulation | 0.90330421 |
| 83 | MP0005408_hypopigmentation | 0.90221333 |
| 84 | MP0002877_abnormal_melanocyte_morpholog | 0.89330964 |
| 85 | MP0009763_increased_sensitivity_to | 0.87887396 |
| 86 | MP0001324_abnormal_eye_pigmentation | 0.86861330 |
| 87 | MP0005448_abnormal_energy_balance | 0.84471012 |
| 88 | MP0001177_atelectasis | 0.84347961 |
| 89 | MP0002234_abnormal_pharynx_morphology | 0.83160146 |
| 90 | MP0003724_increased_susceptibility_to | 0.82363778 |
| 91 | MP0005253_abnormal_eye_physiology | 0.80725529 |
| 92 | MP0004782_abnormal_surfactant_physiolog | 0.79776827 |
| 93 | MP0009785_altered_susceptibility_to | 0.79766190 |
| 94 | MP0001542_abnormal_bone_strength | 0.79107854 |
| 95 | MP0005376_homeostasis/metabolism_phenot | 0.78942637 |
| 96 | MP0002970_abnormal_white_adipose | 0.78644862 |
| 97 | MP0009642_abnormal_blood_homeostasis | 0.77609137 |
| 98 | MP0009765_abnormal_xenobiotic_induced | 0.76802532 |
| 99 | MP0002638_abnormal_pupillary_reflex | 0.76771989 |
| 100 | MP0009115_abnormal_fat_cell | 0.76609639 |
| 101 | MP0001293_anophthalmia | 0.76416732 |
| 102 | MP0003959_abnormal_lean_body | 0.75654394 |
| 103 | MP0009703_decreased_birth_body | 0.75189610 |
| 104 | MP0004381_abnormal_hair_follicle | 0.75028298 |
| 105 | MP0005084_abnormal_gallbladder_morpholo | 0.74887591 |
| 106 | MP0009764_decreased_sensitivity_to | 0.73979123 |
| 107 | MP0000003_abnormal_adipose_tissue | 0.73758996 |
| 108 | MP0000013_abnormal_adipose_tissue | 0.73283759 |
| 109 | MP0001544_abnormal_cardiovascular_syste | 0.73034607 |
| 110 | MP0005385_cardiovascular_system_phenoty | 0.73034607 |
| 111 | MP0003705_abnormal_hypodermis_morpholog | 0.69207328 |
| 112 | MP0008469_abnormal_protein_level | 0.67623788 |
| 113 | MP0006138_congestive_heart_failure | 0.66633814 |
| 114 | MP0005266_abnormal_metabolism | 0.65869933 |
| 115 | MP0001756_abnormal_urination | 0.65804169 |
| 116 | MP0005275_abnormal_skin_tensile | 0.65759283 |
| 117 | MP0003137_abnormal_impulse_conducting | 0.62253074 |
| 118 | MP0006035_abnormal_mitochondrial_morpho | 0.62136480 |
| 119 | MP0000639_abnormal_adrenal_gland | 0.60261500 |
| 120 | MP0005452_abnormal_adipose_tissue | 0.60057961 |
| 121 | MP0003950_abnormal_plasma_membrane | 0.59513398 |
| 122 | MP0000579_abnormal_nail_morphology | 0.57690905 |
| 123 | MP0000427_abnormal_hair_cycle | 0.57472486 |
| 124 | MP0001186_pigmentation_phenotype | 0.57097812 |
| 125 | MP0000230_abnormal_systemic_arterial | 0.56542220 |
| 126 | MP0002282_abnormal_trachea_morphology | 0.55954940 |
| 127 | MP0005220_abnormal_exocrine_pancreas | 0.55593082 |
| 128 | MP0005058_abnormal_lysosome_morphology | 0.55250823 |
| 129 | MP0002233_abnormal_nose_morphology | 0.55225432 |
| 130 | MP0009379_abnormal_foot_pigmentation | 0.54718335 |
| 131 | MP0003953_abnormal_hormone_level | 0.53145046 |
| 132 | MP0008872_abnormal_physiological_respon | 0.49912186 |
| 133 | MP0002060_abnormal_skin_morphology | 0.49793062 |
| 134 | MP0002090_abnormal_vision | 0.47641570 |
| 135 | MP0000647_abnormal_sebaceous_gland | 0.46246772 |
| 136 | MP0008874_decreased_physiological_sensi | 0.44516200 |
| 137 | MP0005379_endocrine/exocrine_gland_phen | 0.43866071 |
| 138 | MP0003638_abnormal_response/metabolism_ | 0.43741654 |
| 139 | MP0001243_abnormal_dermal_layer | 0.40404640 |
| 140 | MP0005164_abnormal_response_to | 0.40132060 |
| 141 | MP0002136_abnormal_kidney_physiology | 0.38821937 |
| 142 | MP0009780_abnormal_chondrocyte_physiolo | 0.37726292 |
| 143 | MP0004142_abnormal_muscle_tone | 0.36778657 |
| 144 | MP0010368_abnormal_lymphatic_system | 0.35312788 |
| 145 | MP0003633_abnormal_nervous_system | 0.35056013 |
| 146 | MP0002168_other_aberrant_phenotype | 0.34356938 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.39136261 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 6.08536533 |
| 3 | Deep venous thrombosis (HP:0002625) | 5.58862240 |
| 4 | Xanthomatosis (HP:0000991) | 5.47718365 |
| 5 | Hyperlipoproteinemia (HP:0010980) | 5.15959719 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 4.96783206 |
| 7 | Prolonged partial thromboplastin time (HP:0003645) | 4.86639741 |
| 8 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.83177033 |
| 9 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.52260987 |
| 10 | Abnormality of glycine metabolism (HP:0010895) | 4.52260987 |
| 11 | Hyperglycinuria (HP:0003108) | 4.44720733 |
| 12 | Hyperammonemia (HP:0001987) | 4.43025436 |
| 13 | Complement deficiency (HP:0004431) | 4.40838133 |
| 14 | Ketosis (HP:0001946) | 4.37868562 |
| 15 | Epidermoid cyst (HP:0200040) | 4.35945232 |
| 16 | Acute necrotizing encephalopathy (HP:0006965) | 4.34182683 |
| 17 | Hyperglycinemia (HP:0002154) | 4.24107868 |
| 18 | Hypoglycemic coma (HP:0001325) | 4.20503559 |
| 19 | Abnormality of alanine metabolism (HP:0010916) | 4.16920653 |
| 20 | Hyperalaninemia (HP:0003348) | 4.16920653 |
| 21 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 4.16920653 |
| 22 | Abnormality of fatty-acid metabolism (HP:0004359) | 4.01204225 |
| 23 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.93784375 |
| 24 | Hypolipoproteinemia (HP:0010981) | 3.92512543 |
| 25 | Mitochondrial inheritance (HP:0001427) | 3.86455199 |
| 26 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.83511878 |
| 27 | Increased hepatocellular lipid droplets (HP:0006565) | 3.82099482 |
| 28 | Increased CSF lactate (HP:0002490) | 3.77670059 |
| 29 | Lipid accumulation in hepatocytes (HP:0006561) | 3.72199083 |
| 30 | Progressive macrocephaly (HP:0004481) | 3.66720261 |
| 31 | Fat malabsorption (HP:0002630) | 3.59843067 |
| 32 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.56292198 |
| 33 | Hypoalphalipoproteinemia (HP:0003233) | 3.52978224 |
| 34 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.50891050 |
| 35 | Exertional dyspnea (HP:0002875) | 3.50848265 |
| 36 | Ketoacidosis (HP:0001993) | 3.48186984 |
| 37 | Abnormality of methionine metabolism (HP:0010901) | 3.34886415 |
| 38 | Renal Fanconi syndrome (HP:0001994) | 3.33352430 |
| 39 | Congenital, generalized hypertrichosis (HP:0004540) | 3.28858617 |
| 40 | Cerebral edema (HP:0002181) | 3.26412837 |
| 41 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.23244461 |
| 42 | Dicarboxylic aciduria (HP:0003215) | 3.23244461 |
| 43 | Abnormality of the common coagulation pathway (HP:0010990) | 3.20515974 |
| 44 | Joint hemorrhage (HP:0005261) | 3.15915672 |
| 45 | Abnormality of serum amino acid levels (HP:0003112) | 3.14233084 |
| 46 | Abnormality of glycolysis (HP:0004366) | 3.11251657 |
| 47 | Increased serum pyruvate (HP:0003542) | 3.11251657 |
| 48 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.09765174 |
| 49 | Abnormality of complement system (HP:0005339) | 3.08874131 |
| 50 | Conjugated hyperbilirubinemia (HP:0002908) | 3.03084794 |
| 51 | Increased serum lactate (HP:0002151) | 2.98205932 |
| 52 | 3-Methylglutaconic aciduria (HP:0003535) | 2.97850281 |
| 53 | Hypercholesterolemia (HP:0003124) | 2.96260923 |
| 54 | Lethargy (HP:0001254) | 2.95845204 |
| 55 | Steatorrhea (HP:0002570) | 2.92818580 |
| 56 | Reduced antithrombin III activity (HP:0001976) | 2.89027671 |
| 57 | Abnormality of the intrinsic pathway (HP:0010989) | 2.86567410 |
| 58 | Hyperbilirubinemia (HP:0002904) | 2.85985425 |
| 59 | CNS demyelination (HP:0007305) | 2.80738831 |
| 60 | Metabolic acidosis (HP:0001942) | 2.79197886 |
| 61 | Generalized aminoaciduria (HP:0002909) | 2.70580119 |
| 62 | Skin nodule (HP:0200036) | 2.70522918 |
| 63 | Respiratory failure (HP:0002878) | 2.65204927 |
| 64 | Hepatic necrosis (HP:0002605) | 2.63993024 |
| 65 | Delayed CNS myelination (HP:0002188) | 2.60249742 |
| 66 | Microvesicular hepatic steatosis (HP:0001414) | 2.57638880 |
| 67 | Brushfield spots (HP:0001088) | 2.55504947 |
| 68 | Abnormality of purine metabolism (HP:0004352) | 2.54624783 |
| 69 | Acute encephalopathy (HP:0006846) | 2.53395346 |
| 70 | Type I transferrin isoform profile (HP:0003642) | 2.50874311 |
| 71 | Degeneration of anterior horn cells (HP:0002398) | 2.50293741 |
| 72 | Abnormality of the anterior horn cell (HP:0006802) | 2.50293741 |
| 73 | Hypoglycemic seizures (HP:0002173) | 2.45604669 |
| 74 | Abnormal gallbladder physiology (HP:0012438) | 2.43056442 |
| 75 | Cholecystitis (HP:0001082) | 2.43056442 |
| 76 | Abnormality of nucleobase metabolism (HP:0010932) | 2.42923677 |
| 77 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.42483175 |
| 78 | Abnormal gallbladder morphology (HP:0012437) | 2.42211311 |
| 79 | Vomiting (HP:0002013) | 2.41594030 |
| 80 | Aplastic anemia (HP:0001915) | 2.41559431 |
| 81 | Myocardial infarction (HP:0001658) | 2.39593808 |
| 82 | Increased intramyocellular lipid droplets (HP:0012240) | 2.39300706 |
| 83 | Exercise intolerance (HP:0003546) | 2.38887917 |
| 84 | Colon cancer (HP:0003003) | 2.38501668 |
| 85 | Acanthocytosis (HP:0001927) | 2.34289666 |
| 86 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.34209086 |
| 87 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.34209086 |
| 88 | Leukodystrophy (HP:0002415) | 2.32432970 |
| 89 | Increased muscle lipid content (HP:0009058) | 2.29529466 |
| 90 | Amniotic constriction ring (HP:0009775) | 2.27160874 |
| 91 | Abnormality of placental membranes (HP:0011409) | 2.27160874 |
| 92 | Pancreatitis (HP:0001733) | 2.26482260 |
| 93 | Irritability (HP:0000737) | 2.26250504 |
| 94 | Gonadotropin excess (HP:0000837) | 2.22887618 |
| 95 | Cholelithiasis (HP:0001081) | 2.21863833 |
| 96 | Hypertriglyceridemia (HP:0002155) | 2.21777495 |
| 97 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.19521463 |
| 98 | Hydroxyprolinuria (HP:0003080) | 2.19223326 |
| 99 | Abnormality of proline metabolism (HP:0010907) | 2.19223326 |
| 100 | Myoglobinuria (HP:0002913) | 2.17845495 |
| 101 | Rhabdomyolysis (HP:0003201) | 2.16163039 |
| 102 | Palpitations (HP:0001962) | 2.15973483 |
| 103 | Oligomenorrhea (HP:0000876) | 2.15398909 |
| 104 | Hepatocellular carcinoma (HP:0001402) | 2.11488470 |
| 105 | Vascular calcification (HP:0004934) | 2.10514409 |
| 106 | Amyloidosis (HP:0011034) | 2.10333437 |
| 107 | Abnormality of the labia minora (HP:0012880) | 2.09125781 |
| 108 | Abnormal biliary tract physiology (HP:0012439) | 2.06703328 |
| 109 | Bile duct proliferation (HP:0001408) | 2.06703328 |
| 110 | Neurofibrillary tangles (HP:0002185) | 2.06461618 |
| 111 | Glycosuria (HP:0003076) | 2.05225293 |
| 112 | Abnormality of urine glucose concentration (HP:0011016) | 2.05225293 |
| 113 | Neoplasm of the adrenal gland (HP:0100631) | 2.04134989 |
| 114 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.03468402 |
| 115 | Methylmalonic aciduria (HP:0012120) | 2.03076517 |
| 116 | Multiple enchondromatosis (HP:0005701) | 2.02743472 |
| 117 | Abnormality of renal resorption (HP:0011038) | 2.02401882 |
| 118 | Gout (HP:0001997) | 2.01167204 |
| 119 | Hepatocellular necrosis (HP:0001404) | 2.00839213 |
| 120 | Spontaneous abortion (HP:0005268) | 1.99880789 |
| 121 | Abnormal cartilage morphology (HP:0002763) | 1.99363320 |
| 122 | Optic disc pallor (HP:0000543) | 1.98357267 |
| 123 | Cerebral hemorrhage (HP:0001342) | 1.97377537 |
| 124 | Renal cortical cysts (HP:0000803) | 1.97238067 |
| 125 | Abnormal lung lobation (HP:0002101) | 1.96716241 |
| 126 | Acanthosis nigricans (HP:0000956) | 1.94260837 |
| 127 | Methylmalonic acidemia (HP:0002912) | 1.93881538 |
| 128 | Opisthotonus (HP:0002179) | 1.93633011 |
| 129 | Supernumerary spleens (HP:0009799) | 1.93202964 |
| 130 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.91473765 |
| 131 | Abnormality of chromosome stability (HP:0003220) | 1.88927768 |
| 132 | Cardiovascular calcification (HP:0011915) | 1.88830068 |
| 133 | Abnormality of the gallbladder (HP:0005264) | 1.88709224 |
| 134 | Spastic diplegia (HP:0001264) | 1.88565708 |
| 135 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.88436745 |
| 136 | Neonatal onset (HP:0003623) | 1.88374153 |
| 137 | Abnormal protein glycosylation (HP:0012346) | 1.85478206 |
| 138 | Abnormal glycosylation (HP:0012345) | 1.85478206 |
| 139 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.85478206 |
| 140 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.85478206 |
| 141 | Elevated hepatic transaminases (HP:0002910) | 1.85132536 |
| 142 | Neoplasm of the colon (HP:0100273) | 1.85073382 |
| 143 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.84754837 |
| 144 | Megaloblastic anemia (HP:0001889) | 1.84398750 |
| 145 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.83612994 |
| 146 | Symptomatic seizures (HP:0011145) | 1.82121686 |
| 147 | Hemorrhage of the eye (HP:0011885) | 1.82100321 |
| 148 | Spastic paraparesis (HP:0002313) | 1.81697047 |
| 149 | Lactic acidosis (HP:0003128) | 1.81582061 |
| 150 | Abnormality of vitamin metabolism (HP:0100508) | 1.81177634 |
| 151 | Epiphyseal stippling (HP:0010655) | 1.80321125 |
| 152 | Nausea (HP:0002018) | 1.79858520 |
| 153 | Abnormal hemoglobin (HP:0011902) | 1.79738496 |
| 154 | Enlarged kidneys (HP:0000105) | 1.79237243 |
| 155 | Hypoproteinemia (HP:0003075) | 1.78226183 |
| 156 | Hepatosplenomegaly (HP:0001433) | 1.72473856 |
| 157 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.72350065 |
| 158 | Abnormality of vitamin B metabolism (HP:0004340) | 1.71149087 |
| 159 | Oral leukoplakia (HP:0002745) | 1.70171852 |
| 160 | Respiratory difficulties (HP:0002880) | 1.68636856 |
| 161 | Clitoromegaly (HP:0000057) | 1.67949095 |
| 162 | Medulloblastoma (HP:0002885) | 1.66681941 |
| 163 | Biliary tract neoplasm (HP:0100574) | 1.63979883 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.95777820 |
| 2 | SIK1 | 4.02791515 |
| 3 | STK39 | 3.24783802 |
| 4 | TRIM28 | 3.19190695 |
| 5 | BUB1 | 3.05540977 |
| 6 | INSRR | 2.96791009 |
| 7 | SRPK1 | 2.78449827 |
| 8 | VRK2 | 2.70254089 |
| 9 | EIF2AK3 | 2.68587835 |
| 10 | PDK4 | 2.61695914 |
| 11 | PDK3 | 2.61695914 |
| 12 | NEK1 | 2.47635883 |
| 13 | TSSK6 | 2.46857188 |
| 14 | MKNK1 | 2.43557522 |
| 15 | CAMK1D | 2.39522752 |
| 16 | OXSR1 | 2.35895203 |
| 17 | ZAK | 2.32116027 |
| 18 | MAP3K12 | 2.31832243 |
| 19 | EPHB1 | 2.30353422 |
| 20 | FGFR4 | 2.27647700 |
| 21 | ERN1 | 2.27332248 |
| 22 | ERBB3 | 2.26615503 |
| 23 | MST1R | 1.97267753 |
| 24 | STK16 | 1.95644397 |
| 25 | MET | 1.95627527 |
| 26 | ERBB4 | 1.91393754 |
| 27 | PLK3 | 1.89723021 |
| 28 | FGFR2 | 1.83135795 |
| 29 | MAP4K2 | 1.79759882 |
| 30 | MKNK2 | 1.79547230 |
| 31 | TRIB3 | 1.78607048 |
| 32 | NUAK1 | 1.75127249 |
| 33 | VRK1 | 1.71860100 |
| 34 | WNK4 | 1.67307709 |
| 35 | PIK3CG | 1.63786464 |
| 36 | MAPKAPK5 | 1.61085666 |
| 37 | EIF2AK1 | 1.60527356 |
| 38 | PRKAA2 | 1.59951566 |
| 39 | FLT3 | 1.58558775 |
| 40 | WNK3 | 1.57580694 |
| 41 | WEE1 | 1.56695911 |
| 42 | TTK | 1.50712873 |
| 43 | CAMK1G | 1.49513805 |
| 44 | ACVR1B | 1.48586376 |
| 45 | PLK4 | 1.46516266 |
| 46 | BRSK2 | 1.42363212 |
| 47 | MAP2K4 | 1.41966267 |
| 48 | BCR | 1.40693508 |
| 49 | TAOK3 | 1.37834432 |
| 50 | TAF1 | 1.35131603 |
| 51 | PDK2 | 1.30837024 |
| 52 | PBK | 1.29671747 |
| 53 | CCNB1 | 1.29505321 |
| 54 | MAPK11 | 1.25999138 |
| 55 | ABL2 | 1.25976784 |
| 56 | CDK6 | 1.24058488 |
| 57 | STK38L | 1.21037711 |
| 58 | MAP3K4 | 1.19757941 |
| 59 | CDC7 | 1.18925616 |
| 60 | NEK9 | 1.16025820 |
| 61 | PIK3CA | 1.14039710 |
| 62 | RPS6KA4 | 1.13056875 |
| 63 | PLK1 | 1.09299817 |
| 64 | EIF2AK2 | 1.06960371 |
| 65 | BMPR2 | 1.06062481 |
| 66 | FRK | 1.05065815 |
| 67 | PKN2 | 0.99537084 |
| 68 | DYRK3 | 0.99384698 |
| 69 | PDPK1 | 0.95743141 |
| 70 | CSNK1G1 | 0.94182100 |
| 71 | EPHB2 | 0.91961327 |
| 72 | TGFBR2 | 0.91681764 |
| 73 | IRAK1 | 0.90675568 |
| 74 | PKN1 | 0.90390781 |
| 75 | CSNK1G3 | 0.88392912 |
| 76 | NTRK1 | 0.86080260 |
| 77 | CAMK2G | 0.83003431 |
| 78 | MAP3K13 | 0.82932830 |
| 79 | TNIK | 0.82740871 |
| 80 | TGFBR1 | 0.81716929 |
| 81 | PRKCQ | 0.81432363 |
| 82 | IRAK2 | 0.80172455 |
| 83 | SGK223 | 0.79503392 |
| 84 | SGK494 | 0.79503392 |
| 85 | JAK2 | 0.79114755 |
| 86 | MAPK15 | 0.78332512 |
| 87 | AURKB | 0.76763225 |
| 88 | CSNK1A1L | 0.76654013 |
| 89 | GSK3A | 0.71707009 |
| 90 | DAPK2 | 0.71454856 |
| 91 | RET | 0.71352020 |
| 92 | PAK4 | 0.70574796 |
| 93 | CASK | 0.70068002 |
| 94 | LATS1 | 0.69571095 |
| 95 | NME1 | 0.67721585 |
| 96 | PDK1 | 0.67121102 |
| 97 | TESK1 | 0.66719791 |
| 98 | MAPK4 | 0.66514693 |
| 99 | CSNK1G2 | 0.66267402 |
| 100 | PRKACG | 0.66157618 |
| 101 | MAP3K3 | 0.62524249 |
| 102 | MAP2K7 | 0.60916833 |
| 103 | CDK19 | 0.60838215 |
| 104 | TIE1 | 0.60532129 |
| 105 | EPHA3 | 0.59640150 |
| 106 | CSNK2A1 | 0.59253241 |
| 107 | ATR | 0.57961643 |
| 108 | LIMK1 | 0.57924858 |
| 109 | GRK1 | 0.57490320 |
| 110 | MAP2K1 | 0.57418424 |
| 111 | CAMK2B | 0.57142823 |
| 112 | KIT | 0.56056647 |
| 113 | CSNK2A2 | 0.55306971 |
| 114 | ADRBK2 | 0.54995438 |
| 115 | IGF1R | 0.54862008 |
| 116 | PTK6 | 0.54671184 |
| 117 | JAK1 | 0.54288679 |
| 118 | CLK1 | 0.53236733 |
| 119 | PINK1 | 0.53065079 |
| 120 | PRKAA1 | 0.51476488 |
| 121 | STK24 | 0.51126967 |
| 122 | CDK3 | 0.49928900 |
| 123 | MAPK12 | 0.49903733 |
| 124 | PLK2 | 0.49337944 |
| 125 | MAP3K7 | 0.48405347 |
| 126 | PRKCZ | 0.46525111 |
| 127 | FGFR1 | 0.46243636 |
| 128 | TYK2 | 0.46211269 |
| 129 | EPHA4 | 0.45033173 |
| 130 | MAP3K2 | 0.44941622 |
| 131 | CSF1R | 0.44614576 |
| 132 | MYLK | 0.43487160 |
| 133 | PAK3 | 0.42291122 |
| 134 | CAMK2D | 0.41882407 |
| 135 | TBK1 | 0.40483905 |
| 136 | TEC | 0.40207900 |
| 137 | TXK | 0.40189982 |
| 138 | CHEK2 | 0.39678230 |
| 139 | PRKD1 | 0.39499965 |
| 140 | DAPK1 | 0.39158181 |
| 141 | ATM | 0.39004116 |
| 142 | MAP3K5 | 0.38563849 |
| 143 | KDR | 0.38540869 |
| 144 | DYRK2 | 0.36987140 |
| 145 | CSNK1E | 0.35840921 |
| 146 | MAP2K3 | 0.35717356 |
| 147 | TRPM7 | 0.35603767 |
| 148 | CDK9 | 0.34939960 |
| 149 | PASK | 0.34445338 |
| 150 | MAP2K6 | 0.33955979 |
| 151 | CDK14 | 0.33594819 |
| 152 | PRKACA | 0.33465586 |
| 153 | LMTK2 | 0.33064561 |
| 154 | RPS6KA5 | 0.32785729 |
| 155 | MST4 | 0.32126964 |
| 156 | OBSCN | 0.31468272 |
| 157 | MAP3K14 | 0.31118165 |
| 158 | PRKCE | 0.30096520 |
| 159 | KSR2 | 0.28014585 |
| 160 | LRRK2 | 0.26869237 |
| 161 | CAMK2A | 0.26620749 |
| 162 | BMPR1B | 0.26002971 |
| 163 | FER | 0.23942758 |
| 164 | DYRK1B | 0.23705518 |
| 165 | STK3 | 0.23624805 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.68195646 |
| 2 | Proteasome_Homo sapiens_hsa03050 | 3.22834486 |
| 3 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 3.08731844 |
| 4 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.03032800 |
| 5 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.02294946 |
| 6 | * Propanoate metabolism_Homo sapiens_hsa00640 | 2.91345528 |
| 7 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.77568330 |
| 8 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.61979611 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.61566540 |
| 10 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.53361668 |
| 11 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.46185651 |
| 12 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.42709691 |
| 13 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.36390287 |
| 14 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.33835575 |
| 15 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.32609565 |
| 16 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.31020081 |
| 17 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.24473951 |
| 18 | Peroxisome_Homo sapiens_hsa04146 | 2.22099353 |
| 19 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.19503669 |
| 20 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.02361899 |
| 21 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.99787537 |
| 22 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.96190313 |
| 23 | Mismatch repair_Homo sapiens_hsa03430 | 1.86711875 |
| 24 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.86244735 |
| 25 | Histidine metabolism_Homo sapiens_hsa00340 | 1.85471073 |
| 26 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.85369220 |
| 27 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.84229207 |
| 28 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.77500825 |
| 29 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.73423611 |
| 30 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.72487366 |
| 31 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.70817044 |
| 32 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.70543946 |
| 33 | RNA polymerase_Homo sapiens_hsa03020 | 1.66545212 |
| 34 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.66265198 |
| 35 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.64518845 |
| 36 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.62575665 |
| 37 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.52041903 |
| 38 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.50805178 |
| 39 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.46675071 |
| 40 | Ribosome_Homo sapiens_hsa03010 | 1.46674886 |
| 41 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.46475575 |
| 42 | Retinol metabolism_Homo sapiens_hsa00830 | 1.44393890 |
| 43 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.42090123 |
| 44 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.41259125 |
| 45 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.39675133 |
| 46 | Carbon metabolism_Homo sapiens_hsa01200 | 1.39497169 |
| 47 | DNA replication_Homo sapiens_hsa03030 | 1.39176233 |
| 48 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.28488610 |
| 49 | Homologous recombination_Homo sapiens_hsa03440 | 1.27887519 |
| 50 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.22562513 |
| 51 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.21912900 |
| 52 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.21046563 |
| 53 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.16952580 |
| 54 | Basal transcription factors_Homo sapiens_hsa03022 | 1.16802470 |
| 55 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.15802884 |
| 56 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.14196956 |
| 57 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.12968524 |
| 58 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.12702108 |
| 59 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.11975578 |
| 60 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.09234757 |
| 61 | Bile secretion_Homo sapiens_hsa04976 | 1.08714353 |
| 62 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.08058917 |
| 63 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.06352529 |
| 64 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.00168139 |
| 65 | ABC transporters_Homo sapiens_hsa02010 | 0.99191904 |
| 66 | Asthma_Homo sapiens_hsa05310 | 0.95182295 |
| 67 | Spliceosome_Homo sapiens_hsa03040 | 0.94728473 |
| 68 | RNA degradation_Homo sapiens_hsa03018 | 0.93652361 |
| 69 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.90869158 |
| 70 | RNA transport_Homo sapiens_hsa03013 | 0.90083197 |
| 71 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.89564164 |
| 72 | Base excision repair_Homo sapiens_hsa03410 | 0.87706235 |
| 73 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.87662515 |
| 74 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.86570020 |
| 75 | Sulfur relay system_Homo sapiens_hsa04122 | 0.84419618 |
| 76 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.81963882 |
| 77 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.81202543 |
| 78 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.81014448 |
| 79 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.74240728 |
| 80 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.68649238 |
| 81 | Purine metabolism_Homo sapiens_hsa00230 | 0.68461784 |
| 82 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.67505105 |
| 83 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.65940510 |
| 84 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.65650281 |
| 85 | Metabolic pathways_Homo sapiens_hsa01100 | 0.61408677 |
| 86 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.59745944 |
| 87 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.57383571 |
| 88 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.57225657 |
| 89 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.55780247 |
| 90 | Lysine degradation_Homo sapiens_hsa00310 | 0.47369518 |
| 91 | Cell cycle_Homo sapiens_hsa04110 | 0.44642021 |
| 92 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.43408872 |
| 93 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.41141802 |
| 94 | Allograft rejection_Homo sapiens_hsa05330 | 0.38056330 |
| 95 | Parkinsons disease_Homo sapiens_hsa05012 | 0.37680300 |
| 96 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.37096668 |
| 97 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.36516653 |
| 98 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.34504632 |
| 99 | Protein export_Homo sapiens_hsa03060 | 0.31702474 |
| 100 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.29256450 |
| 101 | Alzheimers disease_Homo sapiens_hsa05010 | 0.28624237 |
| 102 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.28312720 |
| 103 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.28196051 |
| 104 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.25089372 |
| 105 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.24741832 |
| 106 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.24224482 |
| 107 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.22968626 |
| 108 | Insulin resistance_Homo sapiens_hsa04931 | 0.22633884 |
| 109 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.22283808 |
| 110 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.20392029 |
| 111 | Galactose metabolism_Homo sapiens_hsa00052 | 0.19956166 |
| 112 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.10577322 |
| 113 | Prion diseases_Homo sapiens_hsa05020 | 0.10232789 |
| 114 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.08145671 |
| 115 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.06860108 |
| 116 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.06158415 |
| 117 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.04812532 |
| 118 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.03952768 |
| 119 | Huntingtons disease_Homo sapiens_hsa05016 | 0.03806042 |
| 120 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | -0.1987181 |
| 121 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.1941900 |
| 122 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.1897870 |
| 123 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1786633 |
| 124 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.1762692 |
| 125 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1708844 |
| 126 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1598630 |
| 127 | Lysosome_Homo sapiens_hsa04142 | -0.1460741 |
| 128 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.0507936 |
| 129 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | -0.0235422 |
| 130 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0054326 |

